Pharmacokinetics and Safety of Vilaprisan in Renal Impairment
Status:
Completed
Trial end date:
2019-02-06
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the pharmacokinetics of vilaprisan in subjects with
moderate to severe renal impairment compared with matched subjects with normal renal
function.